Rabies Vaccine for the Elderly

As a professional rabies vaccine manufacturer and developer, AIM Honor provides Rabies Vaccine for the Elderly. The elderly are a high-risk group for rabies exposure due to declining physiological functions, high exposure risk, and increased risk of complications. Their immunization requires adherence to core principles of prioritized enhanced immunity, continuous monitoring of reactions, and combined wound care.

Our vaccines are preservative-free, have minimal local adverse reactions, and possess strong safety characteristics, making them suitable for individuals with underlying medical conditions. They have been included in the emergency immunization catalogs of several geriatric hospitals.

High-risk Characteristics of Rabies Exposure in the Elderly

Weakened Physiological Functions: The elderly have declined immunity, resulting in slow antibody production and low antibody levels after vaccination with conventional vaccines. In addition, their poor wound healing ability makes them prone to secondary bacterial infection.

Higher Exposure Risk: Some elderly people have behaviors such as pet-keeping or farming, and their slow limb reaction leads to a higher probability of being bitten or scratched by animals than young and middle-aged groups.

High Risk of Complications: If infected with rabies, the elderly are likely to be comorbid with underlying diseases, which will worsen the condition, with a fatality rate close to 100%.

Core Principles of Immunization for the Elderly

Priority on Enhanced Immunization: It is recommended to administer a double dose of the first vaccine to improve the efficiency of antibody response.

Full-course Reaction Monitoring: Stay for observation for more than 30 minutes after vaccination, and pay attention to the superimposed risks of underlying diseases and vaccine adverse reactions.

Combined Wound Care: Thorough debridement is required after exposure to reduce the probability of wound infection.

AIM Honor Vaccine: A Protective Option Adapted to the Elderly

The Rabies Vaccine for the Elderly of AIM Honor specifically address the immunization pain points:

High Immunogenicity Adapted to Declined Physical Condition

The conventional vaccine uses the indigenous high-efficiency aG strain, with a potency ≥2.5IU per dose, and the measured average value reaches 6.0IU per dose, which can rapidly stimulate the immune response of the elderly.

For the serum-free vaccine, the antibody GMC (Geometric Mean Concentration) reaches 32.76IU/mL 14 days after vaccination under the 5-dose schedule, with immune persistence for more than 3 months, providing long-term protection for the elderly.

Safety Adapted to People with Underlying Diseases

No preservatives are added to the products. The adverse reactions are mainly mild local reactions, which only last for 1-3 days and will not aggravate the underlying diseases of the elderly. The products have been included in the emergency immunization catalogs of multiple geriatric hospitals.